Clinical Characteristics of Pediatric Optic Neuritis With Myelin Oligodendrocyte Glycoprotein Seropositive: A Cohort Study

Pediatric Neurology - Tập 83 - Trang 42-49 - 2018
Qian Chen1, Guixian Zhao2, Yongheng Huang1, Zhenxin Li2, Xinghuai Sun1,3, Ping Lu4, Yan San4, Min Wang1,3, Guohong Tian1,3
1Department of Ophthalmology, Eye Ear Nose and Throat Hospital of Fudan University, Shanghai, China
2Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China
3State Key Laboratory of Medical Neurobiology, Institutes of Brain Science, Fudan University, Shanghai, China
4Department of Radiology, Eye Ear Nose and Throat Hospital of Fudan University, Shanghai, China

Tài liệu tham khảo

Zhou, 2016, Optic neuritis: a 5-year follow-up study of Chinese patients based on aquaporin-4 antibody status and ages, J Neurol, 263, 1382, 10.1007/s00415-016-8155-7 Long, 2017, Different phenotypes at onset in neuromyelitis optica spectrum disorder patients with aquaporin-4 autoimmunity, Front Neurol, 28, 62 ZhangBao, 2017, The clinical characteristics of AQP4 antibody positive NMO/SD in a large cohort of Chinese Han patients, J Neuroimmunol, 302, 49, 10.1016/j.jneuroim.2016.11.010 Lechner, 2016, Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease, J Neurol Neurosurg Psychiatry, 897, 10.1136/jnnp-2015-311743 Rostasy, 2012, Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis, Arch Neurol, 69, 752, 10.1001/archneurol.2011.2956 Fernandez-Carbonell, 2016, Clinical and MRI phenotype of children with MOG antibodies, Mult Scler, 22, 174, 10.1177/1352458515587751 Nakajima, 2015, Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis, BMJ Open, 5, e007766, 10.1136/bmjopen-2015-007766 Zhou, 2017, MOG-antibody associated demyelinating disease of the CNS: a clinical and pathological study in Chinese Han patients, J Neuroimmunol, 305, 19, 10.1016/j.jneuroim.2017.01.007 Tsuburaya, 2015, Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a Japanese boy with recurrent optic neuritis, Brain Dev, 37, 145, 10.1016/j.braindev.2014.02.002 Beck, 1992, A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group, N Engl J Med, 326, 581, 10.1056/NEJM199202273260901 Jenkins, 2017, Optic neuritis: the eye as a window to the brain, Curr Opin Neurol, 30, 61, 10.1097/WCO.0000000000000414 Yeh, 2016, Pediatric optic neuritis, Neurology, 87, S53, 10.1212/WNL.0000000000002822 Badakere, 2015, Visual outcomes in pediatric optic neuritis, Am J Ophthalmol, 159, 210, 10.1016/j.ajo.2014.10.012 Cakmakli, 2009, Childhood optic neuritis: the pediatric neurologist's perspective, Eur J Paediatr Neurol, 13, 452, 10.1016/j.ejpn.2008.09.003 Havla, 2017, Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration, J Neurol, 264, 139, 10.1007/s00415-016-8333-7 Chalmoukou, 2015, Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis, Neurol Neuroimmunol Neuroinflamm, 2, e131, 10.1212/NXI.0000000000000131 Jarius, 2016, MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin, J Neuroinflammation, 13, 279, 10.1186/s12974-016-0717-1 Jarius, 2016, MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome, J Neuroinflammation, 27, 280, 10.1186/s12974-016-0718-0 Piccolo, 2016, Isolated new onset “atypical” optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up, J Neurol, 263, 370, 10.1007/s00415-015-7983-1 Chang, 2017, Recurrent optic neuritis associated with MOG antibody seropositivity, Neurologist, 22, 101, 10.1097/NRL.0000000000000122 Kitley, 2014, Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study, JAMA Neurol, 71, 276, 10.1001/jamaneurol.2013.5857 Baumann, 2016, Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): extending the spectrum of MOG antibody positive diseases, Mult Scler, 22, 1821, 10.1177/1352458516631038 Tardieu, 2016, Consensus definitions for pediatric MS and other demyelinating disorders in childhood, Neurology, 87, S8, 10.1212/WNL.0000000000002877 Syc, 2012, Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis, Brain, 135, 521, 10.1093/brain/awr264 Fernandes, 2013, Evaluation of inner retinal layers in patients with multiple sclerosis or neuromyelitis optica using optical coherence tomography, Ophthalmology, 120, 387, 10.1016/j.ophtha.2012.07.066 Monteiro, 2012, Quantification of retinal neural loss in patients with neuromyelitis optica and multiple sclerosis with or without optic neuritis using Fourier-domain optical coherence tomography, Invest Ophthalmol Vis Sci, 53, 3959, 10.1167/iovs.11-9324 Tian, 2015, Evaluation of retinal nerve fiber layer and ganglion cell complex in patients with optic neuritis or neuromyelitis optica spectrum disorders using optical coherence tomography in a Chinese cohort, J Ophthalmol, 11, 832784